Yes, many hurdles and we will need a lot of luck. Maybe a rogue executive working for big pharma would be useful too but just maybe .....
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025